Skip to main content
Deepa Rangachari, MD, Oncology, Boston, MA, Beth Israel Deaconess Medical Center

DeepaRangachariMD

Oncology • Boston, MA

Thoracic Cancer

Assistant Professor of Medicine, Harvard Medical School

Join to view full profile

Dr. Rangachari is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Rangachari's full profile

Already have an account?

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2010 - 2014
  • Johns Hopkins University
    Johns Hopkins UniversityChief Residency, Internal Medicine, 2011 - 2012
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Internal Medicine, 2007 - 2010
  • University of Chicago Division of the Biological Sciences The Pritzker School of Medicine
    University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 2007

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2014 - 2025
  • MD State Medical License
    MD State Medical License 2010 - 2015
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Clinical Features of Immune Checkpoint Inhibitor-Associated Autoimmune Hemolytic Anemia: A Series of 14 Cases 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • Paper Proposes New Community-Oriented Fellowship Training Model for Hematologists/Oncologists
    Paper Proposes New Community-Oriented Fellowship Training Model for Hematologists/OncologistsDecember 20th, 2022
  • A First-of-Its-Kind Opportunity to Integrate Training in Medical Oncology, Hematology, and Palliative Care
    A First-of-Its-Kind Opportunity to Integrate Training in Medical Oncology, Hematology, and Palliative CareJune 10th, 2022
  • Anti-PD-1 Success in Advanced NSCLC Persists
    Anti-PD-1 Success in Advanced NSCLC PersistsOctober 8th, 2019
  • Join now to see all

Professional Memberships

Hospital Affiliations

Dr. Deepa Rangachari, Dr. Deepa Rangachari, MD, Dr. D Rangachari